Key points are not available for this paper at this time.
May support 18F-FDG PET/CT differentiation of cardiac tumors; leaves open prospective validation before clinical adoption.
TO THE EDITOR: We read with great interest the recent article by Rahbar et al. titled “Differentiation of Malignant and Benign Cardiac Tumors Using 18F-FDG PET/CT” ([1][1]). The paper is interesting because diagnosis of cardiac malignancy is difficult and poorly defined. For example, it has been
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: